Sign Out
Changes in the liver function test have been observed in some patients receiving Amoxicillin and Clavulanic Acid. Therefore, dosage should be reduced for patients with severe renal impairment. The clinical significance of the change is uncertain but Amoxicillin and Clavulanic Acid should be used with caution in patients with evidence of hepatic dysfunction. Cholestatic jaundice, which may be severe, but is usually reversible, has been reported rarely. Amoxicillin and Clavulanic Acid should be avoided if glandular fever is suspended. Prolonged use may also occasionally result in overgrowth on non-susceptible organisms.
Tab 1 g: Signs and symptoms may not become apparent for up to six weeks after treatment ceased. Erythematous rashes have been associated with glandular fever in patients receiving Amoxicillin.
